Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:MTNOY OTCMKTS:MZDAY OTCMKTS:RNLSY OTCMKTS:SGIOY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMTNOYMTN Group$8.20+0.6%$7.35$3.92▼$8.31$15.04B1.2537,186 shs4,886 shsMZDAYMazda Motor$2.80-1.2%$2.96$2.44▼$4.65$3.52B0.63162,581 shs80,541 shsRNLSYRenault$7.72+0.3%$9.81$7.67▼$11.20$11.41B1.3235,616 shs105,670 shsSGIOYShionogi & Co., Ltd. Unsponsored ADR$8.35-1.1%$8.34$6.53▼$8.99$14.21B0.21108,263 shs60,355 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMTNOYMTN Group+1.94%+1.56%+15.11%+40.40%+93.36%MZDAYMazda Motor-1.05%-0.88%-1.74%-2.78%-39.66%RNLSYRenault-2.04%-21.11%-12.99%-23.31%-28.97%SGIOYShionogi & Co., Ltd. Unsponsored ADR+0.72%+0.12%-0.94%+1.93%-19.10%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMTNOYMTN GroupN/AN/AN/AN/AN/AN/AN/AN/AMZDAYMazda MotorN/AN/AN/AN/AN/AN/AN/AN/ARNLSYRENAULTN/AN/AN/AN/AN/AN/AN/AN/ASGIOYShionogi & Co., Ltd. Unsponsored ADR1.7814 of 5 stars0.05.01.70.01.90.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMTNOYMTN Group 4.00Strong BuyN/AN/AMZDAYMazda Motor 1.50ReduceN/AN/ARNLSYRenault 2.00HoldN/AN/ASGIOYShionogi & Co., Ltd. Unsponsored ADR 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest MZDAY, MTNOY, SGIOY, and RNLSY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/26/2025MTNOYMTN GroupCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Strong-Buy4/25/2025RNLSYRenaultDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMTNOYMTN Group$10.27B1.46$1.17 per share6.99$4.19 per share1.96MZDAYMazda Motor$32.96B0.11$1.35 per share2.07$9.48 per share0.29RNLSYRenault$60.85B0.19$4.44 per share1.74$22.76 per share0.34SGIOYShionogi & Co., Ltd. Unsponsored ADR$2.88B4.94$0.74 per share11.30$5.29 per share1.58Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMTNOYMTN Group-$523.72MN/A0.00∞N/AN/AN/AN/AN/AMZDAYMazda Motor$752.92M$0.584.824.11N/A2.24%8.13%3.69%8/6/2025 (Estimated)RNLSYRenault$150.41MN/A0.002.73N/AN/AN/AN/A7/31/2025 (Estimated)SGIOYShionogi & Co., Ltd. Unsponsored ADR$1.12BN/A14.2312.851.92N/AN/AN/A8/4/2025 (Estimated)Latest MZDAY, MTNOY, SGIOY, and RNLSY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2025Q4 2025MZDAYMazda Motor$0.19$0.27+$0.08$0.12$1,304.72 billion$8.72 billion5/12/2025Q4 2025SGIOYShionogi & Co., Ltd. Unsponsored ADR$0.1654$0.14-$0.0254$0.14$824.23 million$721.77 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMTNOYMTN Group$0.131.59%N/AN/AN/AMZDAYMazda Motor$0.145.01%N/A24.14%N/ARNLSYRenault$0.303.89%N/AN/AN/ASGIOYShionogi & Co., Ltd. Unsponsored ADR$0.151.80%N/AN/AN/ALatest MZDAY, MTNOY, SGIOY, and RNLSY DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/1/2025RNLSYRenault$0.33093.11%5/7/20255/8/20255/27/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMTNOYMTN Group0.480.950.95MZDAYMazda Motor0.321.481.04RNLSYRENAULTN/A1.050.98SGIOYShionogi & Co., Ltd. Unsponsored ADR0.016.636.13Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMTNOYMTN GroupN/AMZDAYMazda MotorN/ARNLSYRenaultN/ASGIOYShionogi & Co., Ltd. Unsponsored ADR1.92%Insider OwnershipCompanyInsider OwnershipMTNOYMTN GroupN/AMZDAYMazda MotorN/ARNLSYRenaultN/ASGIOYShionogi & Co., Ltd. Unsponsored ADRN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMTNOYMTN Group16,2021.83 billionN/ANot OptionableMZDAYMazda Motor48,7831.26 billionN/ANot OptionableRNLSYRenault98,0001.48 billionN/ANot OptionableSGIOYShionogi & Co., Ltd. Unsponsored ADR4,9591.70 billionN/ANot OptionableMZDAY, MTNOY, SGIOY, and RNLSY HeadlinesRecent News About These CompaniesSGIOY | Shionogi & Co. Ltd. ADR Annual Balance Sheet - WSJJuly 15 at 10:03 PM | wsj.comShionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Shares Gap Down - What's Next?July 15 at 1:49 PM | marketbeat.comShionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Trading Up 0.5% - Here's What HappenedJuly 15 at 2:38 AM | marketbeat.comSGIOY or ZTS: Which Is the Better Value Stock Right Now?July 7, 2025 | zacks.comShionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Sets New 12-Month High - Still a Buy?July 2, 2025 | marketbeat.comShionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Shares Gap Up - What's Next?June 23, 2025 | marketbeat.comSGIOY or ZTS: Which Is the Better Value Stock Right Now?June 20, 2025 | zacks.comShionogi’s Naldemedine Gains Approval in China for Opioid-Induced ConstipationMay 29, 2025 | tipranks.comShionogi Amends Tender Offer for Torii Pharmaceutical SharesMay 28, 2025 | tipranks.comShionogi Proposes Governance Structure Overhaul to Enhance Strategic OversightMay 16, 2025 | tipranks.comShionogi & Co. Reports Fiscal Year 2024 Financial Results with Positive OutlookMay 12, 2025 | tipranks.comJapanese drugmaker Shionogi to acquire JT's pharma units in $1.1bn dealMay 7, 2025 | asia.nikkei.comShionogi Expands Pharmaceutical Capabilities with Strategic AcquisitionsMay 7, 2025 | tipranks.comJapan's drugmaker Shionogi to acquire JT's pharma units in $1bn dealMay 7, 2025 | asia.nikkei.comShionogi Falls on Report of $1 Billion Offer to Buy Torii PharmaMay 7, 2025 | bloomberg.comShionogi’s Ensitrelvir Shows Promise in COVID-19 PreventionMarch 12, 2025 | tipranks.comShionogi targets JPY550B revenue through QOL focus and global expansionFebruary 1, 2025 | msn.comShionogi & Co., Ltd. (SGIOY) Q3 2024 Earnings Call TranscriptJanuary 31, 2025 | seekingalpha.comShionogi's RSV antiviral reduces viral load in phase 2 trial of adultsJanuary 30, 2025 | fiercebiotech.comFShionogi & Co. (SGIOY) Upgraded to Buy: What Does It Mean for the Stock?January 27, 2025 | msn.comUS HHS awards Shionogi $375M to develop COVID-19 PrEP therapyJanuary 18, 2025 | bioworld.comBNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMZDAY, MTNOY, SGIOY, and RNLSY Company DescriptionsMTN Group OTCMKTS:MTNOY$8.20 +0.05 (+0.61%) As of 02:04 PM EasternMTN Group Limited, together with its subsidiaries, provides mobile telecommunications services in South Africa, Nigeria, East Africa, West and Central Africa, and the Middle East and North Africa. The company offers data, voice and SMS, digital and fintech, interconnect, and roaming services, as well as sells mobile devices. It also provides network as a service, including subsea cables that offers international connectivity services; terrestrial and metro fiber networks; data centers and cable landing stations; and FTTx, towers, and radio access networks. The company also offers digital financial services, such as access payments, e-commerce, insurance, and lending and remittance services; enterprise services comprising manage networks, unified and cloud communication, security as a service, and Internet of Things; and API products and services for telecommunications, health, government, financial services, entertainment, and other sectors. MTN Group Limited was incorporated in 1994 and is based in Johannesburg, South Africa.Mazda Motor OTCMKTS:MZDAY$2.80 -0.04 (-1.24%) As of 03:59 PM EasternMazda Motor Corporation engages in the manufacture and sale of passenger cars and commercial vehicles in Japan, China, North America, Europe, and internationally. The company was formerly known as Toyo Kogyo Co., Ltd. and changed its name to Mazda Motor Corporation in May 1984. Mazda Motor Corporation was incorporated in 1920 and is headquartered in Hiroshima, Japan.Renault OTCMKTS:RNLSY$7.72 +0.02 (+0.26%) As of 03:59 PM EasternRenault SA engages in the design, manufacture, sale, repair, maintenance, and leasing of motor vehicles in Europe, Eurasia, Africa, the Middle East, the Asia Pacific, and the Americas. It also engages in the design and production of parts and equipment used for manufacturing and operation vehicles. The company operates through Automotive, Sale Financing, and Mobility Services segments. Its Automotive segment produces, sells, and distributes passenger cars and light commercial vehicles; and invests in automotive-sector associates and joint ventures primarily in Nissan. The company's Sale Financing segment offers sale financing, leasing, maintenance, and services contract under the Mobilize Financial Services brand. Its Mobility Services segment provides mobility and energy solutions for electric vehicle users under the Mobilize brand. In addition, it is also involved in the design, manufacture, and sale of passenger cars and light commercial vehicles under the Renault, Dacia, Alpine, and Mobilize brands. Further, the company offers used vehicles and spare parts; and engages in business-to-business powertrain activities, and research and advanced engineering activities. Renault SA was founded in 1898 and is based in Boulogne-Billancourt, France.Shionogi & Co., Ltd. Unsponsored ADR OTCMKTS:SGIOY$8.35 -0.09 (-1.07%) As of 03:51 PM EasternShionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug. It also develops S-872600 an influenza nasal vaccine; S-875670 anCOVID-19 nasal vaccine; S-540956 a nucleic acid adjuvant; S-554110 a nontuberculous mycobacterial infection; S-337395 for RSV infections; S-892216 for COVID-19 therapeutics; Olorofim for invasive aspergillosis; cefiderocol for aerobic gram-negative bacterial infections and infectious diseases; S-268019 a COVID-19 prophylactic vaccine; S-268019 a prophylactic vaccine for COVID-19; ensitrelvir for COVID-19 treatment and prevention; baloxavir for influenza virus infection; S-365598 for HIV infection; and S-555739 for suppressing aggravation of COVID-19. In addition, the company develops S-540956 for nucleic acid adjuvant; S-109802 for post-stroke spasticity; S-151128 for chronic pain; S-588210 and S-531011 for solid tumor; S-309309 for obesity; BPN14770 for Alzheimer's disease and fragile X syndrome; S-588410 for bladder cancer; S-488210 for head and neck squamous cell carcinoma; S-005151 for Acute ischemic stroke and epidermolysis bullosa; Rizmoic for opioid-induced constipation; ADR-001 for decompensated liver cirrhosis; S-222611 for malignant tumor; S-812217 for depression; GRT7039 for pain associated with osteoarthritis of the knee; SDT-001 for inattentive ADHD; S-588410 for esophageal cancer; SR-0379 for cutaneous ulcer; and S-723595 for type 2 diabetes. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era How Goldman Sachs Earnings Help You Strategize Your Portfolio Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.